NBIX insider trading — Neurocrine Biosciences Inc
No open-market insider purchases or sales were filed for Neurocrine Biosciences Inc (NBIX) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.
Updated Oct 16, 2026.
Recent NBIX insider transactions
Every Form 4 filed by Neurocrine Biosciences Inc officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | Onyia Jude | Chief Scientific Officer | A · Grant/award | Direct | 3,587 | — | — | Form 4 |
| Sep 11, 2026 | Onyia Jude | Chief Scientific Officer | F · Tax withholding | Direct | 1,936 | $156.22 | $302K | Form 4 |
| Sep 11, 2026 | Lippoldt Darin | Chief Legal Officer | A · Grant/award | Direct | 4,483 | — | — | Form 4 |
| Sep 11, 2026 | Lippoldt Darin | Chief Legal Officer | F · Tax withholding | Direct | 2,419 | $156.22 | $378K | Form 4 |
| Sep 11, 2026 | Gorman Kevin Charles | Director | A · Grant/award | Direct | 14,343 | — | — | Form 4 |
| Sep 11, 2026 | Gorman Kevin Charles | Director | F · Tax withholding | Direct | 7,839 | $156.22 | $1.22M | Form 4 |
| Sep 11, 2026 | Gano Kyle | Chief Executive Officer | A · Grant/award | Direct | 8,117 | — | — | Form 4 |
| Sep 11, 2026 | Gano Kyle | Chief Executive Officer | F · Tax withholding | Direct | 4,380 | $156.22 | $684K | Form 4 |
| Sep 11, 2026 | Keswani Sanjay Chandru | Chief Medical Officer | A · Grant/award | Direct | 3,914 | — | — | Form 4 |
| Sep 11, 2026 | Keswani Sanjay Chandru | Chief Medical Officer | F · Tax withholding | Direct | 2,112 | $156.22 | $330K | Form 4 |
| Sep 11, 2026 | Delaet Ingrid | Chief Regulatory Officer | A · Grant/award | Direct | 4,483 | — | — | Form 4 |
| Sep 11, 2026 | Delaet Ingrid | Chief Regulatory Officer | F · Tax withholding | Direct | 2,419 | $156.22 | $378K | Form 4 |
| Sep 14, 2026 | Boyer David W. | Chief Corp. Affairs Officer | S · Sale · 10b5-1 | Direct | 826 | $157.45 | $130K | Form 4 |
| Sep 11, 2026 | Cooke Julie | Chief Human Resources Officer | A · Grant/award | Direct | 3,587 | — | — | Form 4 |
| Sep 11, 2026 | Cooke Julie | Chief Human Resources Officer | F · Tax withholding | Direct | 1,936 | $156.22 | $302K | Form 4 |
| Sep 11, 2026 | Boyer David W. | Chief Corp. Affairs Officer | A · Grant/award · 10b5-1 | Direct | 3,587 | — | — | Form 4 |
| Sep 11, 2026 | Boyer David W. | Chief Corp. Affairs Officer | F · Tax withholding · 10b5-1 | Direct | 1,936 | $156.22 | $302K | Form 4 |
| Sep 14, 2026 | Abernethy Matt | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 2,311 | $157.20 | $363K | Form 4 |
| Sep 11, 2026 | Benevich Eric | Chief Commercial Officer | A · Grant/award | Direct | 6,275 | — | — | Form 4 |
| Sep 11, 2026 | Benevich Eric | Chief Commercial Officer | F · Tax withholding | Direct | 3,386 | $156.22 | $529K | Form 4 |
| Sep 11, 2026 | Abernethy Matt | Chief Financial Officer | A · Grant/award · 10b5-1 | Direct | 5,020 | — | — | Form 4 |
| Sep 11, 2026 | Abernethy Matt | Chief Financial Officer | F · Tax withholding · 10b5-1 | Direct | 2,709 | $156.22 | $423K | Form 4 |
| Sep 9, 2026 | Benevich Eric | Chief Commercial Officer | M · Option exercise · 10b5-1 | Direct | 3,194 | $43.24 | $138K | Form 4 |
| Sep 9, 2026 | Benevich Eric | Chief Commercial Officer | S · Sale · 10b5-1 | Direct | 2,154 | $154.61 | $333K | Form 4 |
| Sep 2, 2026 | Sherwin Stephen A | Director | G · Gift | Direct | 1,000 | — | — | Form 4 |
| Aug 4, 2026 | Onyia Jude | Chief Scientific Officer | G · Gift | Direct | 2,409 | — | — | Form 4 |
| Jul 29, 2026 | Norwalk Leslie V | Director | M · Option exercise · 10b5-1 | Direct | 842 | $139.43 | $117K | Form 4 |
| Jul 28, 2026 | Norwalk Leslie V | Director | S · Sale · 10b5-1 | Direct | 1,250 | $182.01 | $228K | Form 4 |
NBIX insider trading FAQ
Are insiders buying NBIX stock?
Not on the open market. In the last 90 days, Neurocrine Biosciences Inc insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading NBIX?
No insider bought or sold on the open market in the last 90 days.
Where does NBIX insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.